Skin odor signatures may shift with age - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Skin odor signatures may shift with age

  • By

  • Andrea Surnit

  • October 14, 2026

  • 4 min

Share

Clinical Scorecard: Skin odor signatures may shift with age

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Skin odor signatures may shift with age
Key MechanismsSkin odor profiles reflect glandular secretions and microbial metabolism. Age-associated patterns include acidic VOCs in infancy, androgen-related compounds during puberty, and 2-nonenal in older populations; the proposed oxidative mechanism for 2-nonenal has not been experimentally established. Corynebacterium, Staphylococcus, and Cutibacterium acnes were associated with production of different VOCs.
Target PopulationPeople across the lifespan; the review also describes sex-related differences during reproductive age and menstrual-cycle-associated variation in female profiles.
Care SettingCare setting described in the source article.

Key Highlights

  • The narrative review included 55 studies; the median sample size among included studies was 35 participants.
  • Fatty acids were the most abundant chemical class, and 3-methyl-2-hexenoic acid was identified as a characteristic axillary odorant.
  • Infant profiles were dominated by acidic VOCs; puberty was associated with androgen-related steroid VOCs and increased branched-chain fatty acids.
  • In older populations, studies reported emergence of 2-nonenal, with concentrations increasing after age 40 years.
  • Disease-detection evidence, including studies of diabetes and melanoma, was preliminary; most studies enrolled fewer than 50 participants and lacked independent validation.

Guideline-Based Recommendations

Diagnosis

  • The review does not establish skin odor profiling as a diagnostic method for disease.

Management

  • The authors called for standardized analytical protocols and rigorous validation before odor-based approaches move toward clinical use.

Monitoring & Follow-up

  • The authors identified longitudinal studies and normative reference data as research needs.

Risks

  • Potential influences such as diet, medication use, and hygiene were controlled inconsistently across studies.
  • The evidence base was limited by predominantly cross-sectional designs, small samples, methodological variation, and insufficient independent validation.

Patient & Prescribing Data

The review describes skin VOC patterns across age and sex; it does not provide prescribing data or treatment recommendations.

No treatments were evaluated. Potential clinical applications in disease detection and health monitoring were described as preliminary.

Clinical Best Practices

  • The review reports limited longitudinal evidence and small samples in studies of age-associated odor patterns.
  • The review reports that disease-detection studies generally lacked independent validation; odor signatures are not established as diagnostic tests.
  • The authors identified standardized analytical protocols, control of relevant confounders, longitudinal studies, and normative reference data as research needs.

Related Resources & Content

Original Source(s)

Related Content